While the mechanism of action of gold-containing drugs in the treatment of rheumatoid arthritis has never been fully elucidated, the inhibition of mitochondrial thioredoxin reductase has been suggested as a mediator of therapeutic response [20]. Here, PRDX5 is linked to rheumatoid arthritis.